| BBB | Blood–brain barrier |
| BD | Bipolar disorder |
| B-GOS | Galacto-oligosaccharide |
| CHR | Clinical high risk |
| CNS | Central nervous system |
| CRP | C-Reactive protein |
| CSF | Cerebrospinal fluid |
| DAT | Dopamine transporter |
| DISC | Disrupted-in-schizophrenia 1 |
| DSM-5-TR | Diagnostic and Statistical Manual of Mental Disorders, 5th edition, Text Revision |
| FEP | First-episode psychosis |
| FES | First-episode schizophrenia |
| GAT | GABA transporter |
| GABA | γ-Aminobutyric acid |
| GBA | Gut–brain axis |
| GF | Germ-free |
| GI | Gastrointestinal |
| HPA Axis | Hypothalamic–pituitary–adrenal axis |
| 5-HT | 5-Hydroxytryptamine, Serotonin |
| INF | Interferon |
| IL | Interleukin |
| IP3 | Inositol 1,4,5-triphosphate |
| LSD | Lysergic acid diethylamide |
| LPS | Lipopolysaccharide |
| MIA | Maternal immune activation |
| MK-801 | Dizocilpine |
| α-MSH | α-Melanocyte-stimulating hormone |
| NAC | N-Acetylcysteine |
| NMDA | N-Methyl-D-aspartate |
| NMDAR | N-Methyl-D-aspartate glutamate receptor |
| PVIs | Parvalbumin interneurons |
| PCP | Phencyclidine |
| PET | Positron emission tomography |
| PFC | Prefrontal cortex |
| RNS | Reactive nitrogen species |
| ROS | Reactive oxygen species |
| SCFA | Short chain fatty acid |
| TGF-β1 | Transforming growth factor-β1 |
| TNF | Tumor necrosis factor |
| VTA | Ventral tegmental area |